BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15877526)

  • 1. Bisphosphonates and bone metastases: current status and future directions.
    Krempien R; Niethammer A; Harms W; Debus J
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):295-305. PubMed ID: 15877526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to managing bone metastases from breast cancer: the role of bisphosphonates.
    Mystakidou K; Katsouda E; Stathopoulou E; Vlahos L
    Cancer Treat Rev; 2005 Jun; 31(4):303-11. PubMed ID: 16039956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates: clinical experience.
    Coleman RE
    Oncologist; 2004; 9 Suppl 4():14-27. PubMed ID: 15459426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate therapy for patients with breast carcinoma.
    Plunkett TA; Rubens RD
    Cancer; 2003 Feb; 97(3 Suppl):854-8. PubMed ID: 12548586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates: reducing the risk of skeletal complications from bone metastasis.
    Costa L
    Breast; 2007 Dec; 16 Suppl 3():S16-20. PubMed ID: 18032044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of bisphosphonates in breast cancer.
    Coleman RE
    Breast; 2004 Dec; 13 Suppl 1():S19-28. PubMed ID: 15585379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current use of bisphosphonates in clinical oncology].
    Vrbanec D; Plestina S; Belev B; Unusić J; Pavlinić-Diminić V
    Lijec Vjesn; 1999; 121(9-10):296-301. PubMed ID: 19658372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bisphosphonates in malignant hypercalcemia and bone pain].
    Lamy O
    Rev Med Suisse Romande; 2004 Feb; 124(2):111-4. PubMed ID: 15095627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates: expanded roles in the treatment of patients with cancer.
    Viale PH; Sanchez Yamamoto D
    Clin J Oncol Nurs; 2003; 7(4):393-401. PubMed ID: 12929272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results. International Bone and Cancer Study Group (IBCG).
    Diel IJ; Mundy GR
    Br J Cancer; 2000 Apr; 82(8):1381-6. PubMed ID: 10780514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The application advances of bisphosphonates in bone metastasis].
    Liang P
    Zhongguo Gu Shang; 2008 Jun; 21(6):480-2. PubMed ID: 19108448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of bisphosphonates in cancer patients.
    Wu S; Dahut WL; Gulley JL
    Acta Oncol; 2007; 46(5):581-91. PubMed ID: 17562434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the horizon: can bisphosphonates prevent bone metastases?
    Coleman R
    Breast; 2007 Dec; 16 Suppl 3():S21-7. PubMed ID: 17988867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer.
    Clemons M; Dranitsaris G; Cole D; Gainford MC
    Oncologist; 2006 Mar; 11(3):227-33. PubMed ID: 16549806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer.
    Liauw W; Segelov E; Lih A; Dunleavy R; Links M; Ward R
    BMC Cancer; 2005 Jul; 5():89. PubMed ID: 16048654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of bisphosphonate treatment in clinical practice.
    Aapro MS
    Semin Oncol; 2007 Dec; 34(6 Suppl 4):S28-32. PubMed ID: 18068488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease.
    Dunstan CR; Felsenberg D; Seibel MJ
    Nat Clin Pract Oncol; 2007 Jan; 4(1):42-55. PubMed ID: 17183355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of bisphosphonates in prostate cancer.
    Oades GM; Coxon J; Colston KW
    Prostate Cancer Prostatic Dis; 2002; 5(4):264-72. PubMed ID: 12627210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of bisphosphonates in cancer therapy.
    Lüftner D; Henschke P; Possinger K
    Anticancer Res; 2007; 27(4A):1759-68. PubMed ID: 17649770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary management of bone complications in prostate cancer and optimizing outcomes of bisphosphonate therapy.
    Saad F; Sternberg CN
    Nat Clin Pract Urol; 2007 Feb; 4 Suppl 1():S3-13. PubMed ID: 17264863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.